Maria Ida Bonetti

发表

Rosiglitazone promotes the differentiation of Langerhans cells and inhibits that of other dendritic cell types from CD133 positive hematopoietic precursors.

P. Romagnoli, A. Bosi, B. Mazzanti, 2014, Histology and histopathology.

Multilineage Dysplasia as Assessed by Immunophenotype in Acute Myeloid Leukemia: A Prognostic Tool in a Genetically Undefined Category

F. Annunziato, F. Mannelli, A. Bosi, 2020, Cancers.

Multilineage dysplasia as assessed by immunophenotype has no impact on clinical-biological features and outcome of NPM1-mutated acute myeloid leukemia.

M. Benelli, F. Mannelli, A. Bosi, 2015, Experimental hematology.

CXCR4 expression accounts for clinical phenotype and outcome in acute myeloid leukemia

F. Mannelli, A. Bosi, G. Longo, 2014, Cytometry. Part B, Clinical cytometry.

CEBPA–double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological features

M. Chiarini, M. Benelli, F. Mannelli, 2016, Haematologica.

Early peripheral blast cell clearance predicts minimal residual disease status and refines disease prognosis in acute myeloid leukemia

M. Chiarini, F. Mannelli, A. Bosi, 2020, American journal of hematology.

Early peripheral clearance of leukemia-associated immunophenotypes in AML: centralized analysis of a randomized trial.

F. Mannelli, A. Bosi, A. Rambaldi, 2020, Blood advances.

Dendritic cells with lymphocyte-stimulating activity differentiate from human CD133 positive precursors.

P. Romagnoli, A. Bosi, M. Monici, 2011, Blood.

Differentiation of Human Hematopoietic Progenitor Cells Into Dendritic Cells In Vitro Under Stimulation of PPAR-Gamma

P. Romagnoli, A. Bosi, A. Parenti, 2019, Archives of Clinical and Biomedical Research.